Cargando…
Treatment of uveal melanoma: where are we now?
Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop metastatic disease. Outcomes for those with metastatic disease remain dismal due to a lack of effective therapies. The unique...
Autores principales: | Yang, Jessica, Manson, Daniel K., Marr, Brian P., Carvajal, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824910/ https://www.ncbi.nlm.nih.gov/pubmed/29497459 http://dx.doi.org/10.1177/1758834018757175 |
Ejemplares similares
-
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz, Benjamin A, et al.
Publicado: (2017) -
Metastatic disease from uveal melanoma: treatment options and future prospects
por: Carvajal, Richard D, et al.
Publicado: (2017) -
Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021) -
Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017) -
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)